-
241
The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance
Published 2021-02-01Subjects: Get full text
Article -
242
The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends?
Published 2022-07-01Subjects: Get full text
Article -
243
Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
Published 2022-03-01Subjects: Get full text
Article -
244
The role of magnetic resonance imaging in the evaluation of thalassemic syndromes: current practice and future perspectives
Published 2014-09-01Subjects: “…thalassemia major, magnetic resonance imaging, iron overload.…”
Get full text
Article -
245
Association between Iron Intake and Progression of Knee Osteoarthritis
Published 2022-04-01Subjects: Get full text
Article -
246
Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH
Published 2023-08-01Subjects: Get full text
Article -
247
Contemporary non-invasive methods for the diagnosis of early cardiac dysfunction in young patients with beta-thalassemia major
Published 2022-04-01Subjects: “…cardiomyopathy due to iron overload…”
Get full text
Article -
248
Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy
Published 2022-08-01Subjects: Get full text
Article -
249
A study on ECG and cardiac functional changes in patients with B-thalassemia major
Published 2022-01-01Subjects: Get full text
Article -
250
Comparative efficacy, safety, and cost of iron chelation monotherapy vs. combination therapy in pediatric beta-thalassemia major: a single-center retrospective study
Published 2022-03-01Subjects: “…thalassemia; children; iron overload; chelation agents; cost…”
Get full text
Article -
251
-
252
-
253
-
254
-
255
Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study
Published 2023-01-01Subjects: “…Iron overload…”
Get full text
Article -
256
The Impact of the Epigenetic Cancer Drug Azacitidine on Host Immunity: The Role of Myelosuppression, Iron Overload and <i>tp53</i> Mutations in a Zebrafish Model
Published 2019-09-01“…Together, we propose that myelosuppression, iron overload and <i>TP53</i> mutations may represent the host variables that compromise the azacitidine efficacy.…”
Get full text
Article -
257
-
258
Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial
Published 2022-01-01“…Background: Beta-thalassemia major patients typically require chronic transfusion and iron-chelating agents to reduce serum iron overload. Osveral® is an available Iranian brand name of deferasirox used by majority of thalassemic patients. …”
Get full text
Article -
259
Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis
Published 2023-01-01Subjects: Get full text
Article -
260
Amelioration effects of the soybean lecithin–gallic acid complex on iron-overload-induced oxidative stress and liver damage in C57BL/6J mice
Published 2023-12-01“…In vivo, C57BL/6J mice were randomized into 4 groups: control, iron-overloaded, iron-overloaded + deferoxamine, and iron-overloaded + SL-GAC. …”
Get full text
Article